Biotech Values

[DewDiligence]

Nothing about BSX’s 2006 acquisition of Guidant has worked out well for BSX and that includes income taxes:

http://www.sec.gov/Archives/edgar/data/885725/000088572511000059/form8-kirsnoticeofdeficien.htm

On December 1, 2011, we received a Notice of Deficiency from the Internal Revenue Service (IRS) claiming that we owe additional net taxes of $581 million, plus interest and penalties, based on an audit of the 2004, 2005 and 2006 tax years of Guidant Corporation and its subsidiaries as they existed in that time period.